Evidence map›Paper›PMID 31581697›Full record

ArticleInternational journal of molecular sciences2019

Antidiabetic and Antihyperlipidemic Effects of Sulphurenic Acid, a Triterpenoid Compound from

Cheng-Hsiu Lin, Li-Wei Hsiao, Yueh-Hsiung Kuo, Chun-Ching Shih

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Evidence-Based Nutraceuticals Derived fromFoods (Basel, Switzerland) · 2025
    Review
  3. Article
  4. Article
  5. Anti-Inflammatory Effect of Medicinal FungusFood technology and biotechnology · 2024
    Article
  6. Review
  7. The Ethyl Acetate Extract ofInternational journal of molecular sciences · 2024
    Article
  8. Article
  9. Antidiabetic and Immunoregulatory Activities of Extract ofInternational journal of molecular sciences · 2023
    Article
  10. Antidiabetic and antihyperlipidemic activities ofFood & nutrition research · 2023
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 1 country.

Cheng-Hsiu LinDepartment of Internal Medicine, Fengyuan Hospital, Ministry of Health and Welfare, Fengyuan District, Taichung 42055, Taiwan. keny71@pchome.com.tw.
Li-Wei HsiaoDivision of Endocrinology and Metabolism, Chang Bing Show Chwan Memorial Hospital, Changhua 505, Taiwan. kmccenor@gmail.com.
Yueh-Hsiung KuoDepartment of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University, Taichung 40402, Taiwan. kuoyh@mail.cmu.edu.tw.ORCID 0000-0001-5935-6755
Chun-Ching ShihGraduate Institute of Biotechnology and Biomedical Engineering, College of Health Science, Central Taiwan University of Science and Technology, No.666 Buzih Road, Beitun District, Taichung 40601, Taiwan. ccshih@ctust.edu.tw.ORCID 0000-0003-4264-2602
Central Taiwan University of Science and Technology · TWChang Bing Show Chwan Memorial Hospital · TWChina Medical University · TWMinistry of Health and Welfare · TW

Funding

Central Taiwan University of Science and Technology and Chang Bing Show-Chwan Memorial Hospital, Taiwan, ROC CTU107-C-028
6 · The paper itself

Abstract

The present study was designed to evaluate the protective effect of sulphurenic acid (SA), a pure compound from

Indexed as

AnimalsAntrodiaBiomarkersDiabetes Mellitus, ExperimentalDisease Models, AnimalGene Expression RegulationHypoglycemic AgentsHypolipidemic AgentsLiverMiceMolecular StructureProto-Oncogene Proteins c-aktRNA, MessengerTriterpenesBiomarkersHypoglycemic AgentsHypolipidemic AgentsProto-Oncogene Proteins c-aktRNA, MessengerTriterpenesAkt phosphorylationdiabetesglucose transporter 4streptozotocinsulphurenic acid

Identifiers

PMID31581697
PMCPMC6801777
OpenAlexW2978673693

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.